<SEC-DOCUMENT>0001649553-25-000046-index.html : 20250210 <SEC-HEADER>0001649553-25-000046.hdr.sgml : 20250210 <ACCEPTANCE-DATETIME>20250210110733 ACCESSION NUMBER: 0001649553-25-000046 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20250210 DATE AS OF CHANGE: 20250210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Annovis Bio, Inc. CENTRAL INDEX KEY: 0001477845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262540421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91306 FILM NUMBER: 25604388 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DRIVE, SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-875-3192 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DRIVE, SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: QR Pharma, Inc. DATE OF NAME CHANGE: 20091202 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CVI Investments, Inc. CENTRAL INDEX KEY: 0001649553 ORGANIZATION NAME: IRS NUMBER: 981253664 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: P.O. BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 345-949-8080 MAIL ADDRESS: STREET 1: P.O. BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24 <SEQUENCE>2 <FILENAME>anvs-sc13_exi.pdf <DESCRIPTION>LIMITED POWER OF ATTORNEY <TEXT> Document 2 - file: anvs-sc13_exi.pdf
</DOCUMENT> <DOCUMENT> <TYPE>EX-99 <SEQUENCE>3 <FILENAME>anvs-sc13g_exii.pdf <DESCRIPTION>JOINT FILING AGREEMENT <TEXT> Document 3 - file: anvs-sc13g_exii.pdf
</DOCUMENT> </SEC-DOCUMENT>